Startseite>>Peptides>>Gastric Inhibitory Polypeptide (3-42) (human)

Gastric Inhibitory Polypeptide (3-42) (human)

Katalog-Nr.GA21894

Gastric Inhibitory Polypeptide (3-42) (Mensch) wirkt als Glucose-abhÄngiger insulinotroper Polypeptid (GIP)-Rezeptorantagonist, der die insulinsekretierenden und metabolischen Wirkungen von GIP in vivo moderiert.

Products are for research use only. Not for human use. We do not sell to patients.

Gastric Inhibitory Polypeptide (3-42) (human) Chemische Struktur

Cas No.: 1802086-25-4

Größe Preis Lagerbestand Menge
0.5mg
79,00 $
Auf Lager
1mg
142,00 $
Auf Lager
5mg
558,00 $
Auf Lager
10mg
891,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Gastric inhibitory polypeptide (3-42) represents the major physiological degradation product of gastric inhibitory polypeptide (GIP). It is generated by proteolytic processing of GIP by dipeptidyl peptidase IV (DPP IV).

Bewertungen

Review for Gastric Inhibitory Polypeptide (3-42) (human)

Average Rating: 5 ★★★★★ (Based on Reviews and 10 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Gastric Inhibitory Polypeptide (3-42) (human)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.